by dmsAdmin | Aug 5, 2024
Gadolinium-based contrast agents (GBCAs) are the only approved class of drugs for use with MRI in the United States. There has been increasing concern among radiologists about potential legal exposure from its use. Several patients have come forward reporting adverse...
by dmsAdmin | Jul 6, 2024
Over the past few years, the imaging community has had a whirlwind of technological advances and the introduction of a handful of new imaging agents, especially in the PET/CT space. In this article, we will explore one of the more impactful PET/CT imaging agent that...
by dmsAdmin | Jun 4, 2024
When hospitals and imaging facilities purchase new equipment, such as an MRI, CT, or PET/CT camera, there is often a period of down-time during construction or installation. In most instances, the hospital is responsible for finding an interim imaging provider to...
by dmsAdmin | Sep 24, 2020
As patients who put off medical services surge back into the healthcare system, radiology and imaging departments are feeling the impact. Imaging departments who experienced historically low volumes in the Spring are now faced with backlogs that stretch weeks. The...
by dmsAdmin | Aug 14, 2020
Imaging studies always require a good balance between patient comfort and efficacy of the imaging work. For many years, the only option on the MRI market was a closed bore machine, essentially a tube that patients lie inside. The main problem with these is...
